TURBUHALER

DEVICE3 trials

Sponsors

GlaxoSmithKline, AstraZeneca

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 1

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.

CompletedNCT06732882

AstraZenecaAsthma

Start: 2025-02-27End: 2025-05-29Updated: 2025-06-05

Phase 4

Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices

CompletedNCT02184624

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-08-28End: 2015-07-31Updated: 2017-05-23

To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma

CompletedNCT02195284

GlaxoSmithKlineAsthma

Start: 2014-11-30End: 2015-05-31Updated: 2015-11-23